BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 15652977)

  • 21. Phenotypic and genetic characterization of enteropathogenic Escherichia coli (EPEC) and entero-aggregative E. coli (EAEC) from diarrhoeal and non-diarrhoeal children in Libya.
    Dow MA; Tóth I; Malik A; Herpay M; Nógrády N; Ghenghesh KS; Nagy B
    Comp Immunol Microbiol Infect Dis; 2006; 29(2-3):100-13. PubMed ID: 16626804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shiga toxin-negative attaching and effacing Escherichia coli: distinct clinical associations with bacterial phylogeny and virulence traits and inferred in-host pathogen evolution.
    Bielaszewska M; Middendorf B; Köck R; Friedrich AW; Fruth A; Karch H; Schmidt MA; Mellmann A
    Clin Infect Dis; 2008 Jul; 47(2):208-17. PubMed ID: 18564929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caspases-3, -8, and -9 are required for induction of epithelial cell apoptosis by enteropathogenic E. coli but are dispensable for increased paracellular permeability.
    Flynn AN; Buret AG
    Microb Pathog; 2008 Apr; 44(4):311-9. PubMed ID: 18054197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The rise and rise of enteropathogenic Escherichia coli.
    Robins-Browne RM
    S Afr Med J; 2007 Nov; 97(11 Pt 3):1182-6. PubMed ID: 18250933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of colonization dynamics and pathology of mice infected with enteropathogenic Escherichia coli, enterohaemorrhagic E. coli and Citrobacter rodentium.
    Mundy R; Girard F; FitzGerald AJ; Frankel G
    FEMS Microbiol Lett; 2006 Dec; 265(1):126-32. PubMed ID: 17034412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Classic enteropathogenic Escherichia coli].
    Kallas MR; Scaletsky IC; Fagundes-Neto U
    Arq Gastroenterol; 1997; 34(1):62-8. PubMed ID: 9458962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements.
    Frankel G; Phillips AD; Rosenshine I; Dougan G; Kaper JB; Knutton S
    Mol Microbiol; 1998 Dec; 30(5):911-21. PubMed ID: 9988469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Balance of bacterial pro- and anti-inflammatory mediators dictates net effect of enteropathogenic Escherichia coli on intestinal epithelial cells.
    Sharma R; Tesfay S; Tomson FL; Kanteti RP; Viswanathan VK; Hecht G
    Am J Physiol Gastrointest Liver Physiol; 2006 Apr; 290(4):G685-94. PubMed ID: 16322091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Escherichia coli O125ac:H6 encompasses atypical enteropathogenic E. coli strains that display the aggregative adherence pattern.
    Barros SF; Abe CM; Rocha SP; Ruiz RM; Beutin L; Trabulsi LR; Elias WP
    J Clin Microbiol; 2008 Dec; 46(12):4052-5. PubMed ID: 18923012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An overview of atypical enteropathogenic Escherichia coli.
    Hernandes RT; Elias WP; Vieira MA; Gomes TA
    FEMS Microbiol Lett; 2009 Aug; 297(2):137-49. PubMed ID: 19527295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enteropathogenic Escherichia coli inhibits butyrate uptake in Caco-2 cells by altering the apical membrane MCT1 level.
    Borthakur A; Gill RK; Hodges K; Ramaswamy K; Hecht G; Dudeja PK
    Am J Physiol Gastrointest Liver Physiol; 2006 Jan; 290(1):G30-5. PubMed ID: 16150873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the virulence factor, BfpA, by enteropathogenic Escherichia coli is essential for apoptosis signalling but not for NF-kappaB activation in host cells.
    Melo AR; Lasunskaia EB; de Almeida CM; Schriefer A; Kipnis TL; Dias da Silva W
    Scand J Immunol; 2005 Jun; 61(6):511-9. PubMed ID: 15963045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of enteropathogenic Escherichia coli(EPEC) diarrhoea in children.
    Mani R; Udgaonkar U; Pawar S
    Indian J Pathol Microbiol; 2003 Jan; 46(1):118-20. PubMed ID: 15027751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection of rabbits against enteropathogenic Escherichia coli (EPEC) using an intimin null mutant.
    Stakenborg T; Vandekerchove D; Mariën J; Laevens H; Imberechts H; Peeters J
    BMC Vet Res; 2006 Jun; 2():22. PubMed ID: 16796739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enteropathogenic Escherichia coli (EPEC) effector-mediated suppression of antimicrobial nitric oxide production in a small intestinal epithelial model system.
    Maresca M; Miller D; Quitard S; Dean P; Kenny B
    Cell Microbiol; 2005 Dec; 7(12):1749-62. PubMed ID: 16309461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shiga toxin-producing Escherichia coli: an overview.
    Gyles CL
    J Anim Sci; 2007 Mar; 85(13 Suppl):E45-62. PubMed ID: 17085726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteomic analysis of the binding partners to enteropathogenic Escherichia coli virulence proteins expressed in Saccharomyces cerevisiae.
    Hardwidge PR; Donohoe S; Aebersold R; Finlay BB
    Proteomics; 2006 Apr; 6(7):2174-9. PubMed ID: 16552782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cortactin is essential for F-actin assembly in enteropathogenic Escherichia coli (EPEC)- and enterohaemorrhagic E. coli (EHEC)-induced pedestals and the alpha-helical region is involved in the localization of cortactin to bacterial attachment sites.
    Cantarelli VV; Kodama T; Nijstad N; Abolghait SK; Iida T; Honda T
    Cell Microbiol; 2006 May; 8(5):769-80. PubMed ID: 16611226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clonal relationships determined by multilocus sequence typing among enteropathogenic Escherichia coli isolated in Brazil.
    Pitondo-Silva A; Minarini LA; Camargo IL; Darini AL
    Can J Microbiol; 2009 Jun; 55(6):672-9. PubMed ID: 19767837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Multitalented lymphostatin].
    Klapproth JM; Meyer F
    Dtsch Med Wochenschr; 2009 Feb; 134(9):417-20. PubMed ID: 19224428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.